Interim results from this prospective validation study, presented by Sedghi et al. at the European Stroke Organisation Conference (ESOC) 2025, demonstrated excellent diagnostic accuracy of the RVV assay for detecting factor Xa inhibitor activity in acute ischemic stroke patients. The gene discussed is F10; the disease is Stroke.